Scarica l'app Stockscreener
85.60
0.81%
-0.70
Dopo l'orario di chiusura:
85.68
0.08
+0.09%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
Does ACS Endorsement of Cologuard Shape the Bull Case for Abbott Laboratories (ABT) in Cancer Screening? - simplywall.st
Abbott Laboratories stock (US0028241000): Insider activity stays in focus - AD HOC NEWS
Is ACS’s Cologuard Endorsement Reshaping the Investment Case for Abbott Laboratories (ABT)? - Yahoo Finance
Trump Clears Way for Companies to Avoid Taxes in Havens Including Malta and Cyprus - The New York Times
Piper Sandler Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $115 - 富途牛牛
BSX vs. ABT: Which Medical Stock Has More Upside Potential? - TradingView
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know - Yahoo Finance
Is Abbott Laboratories Stock Underperforming the Dow? - Barchart.com
Abbott gets European OK to market world’s first dual glucose-ketone sensor - Crain's Chicago Business
A Look At Abbott Laboratories (ABT) Valuation After New Approvals For Libre Duo And Ultreon 3.0 - simplywall.st
Abbott Laboratories stock (US0028241000): focus on valuation as regulatory AI approvals frame growth - AD HOC NEWS
Abbott Labs Settles Ill. Genetic Privacy Suit - Law360
Abbott Laboratories stock (US0028241000): regulatory clearances for AI cardiology and glucose-ketone - AD HOC NEWS
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views? - Yahoo Finance
Abbott obtains CE mark for duo of glucose-ketone monitors - Yahoo Finance
Abbott Clears AI Cardiology And Dual Sensors As Shares Face Pressure - simplywall.st
Abbott (ABT) Wins FDA and EU Approval for an AI-Powered Tool That Guides Artery Stent Placement - Insider Monkey
Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance Singapore
10 Dividend Growth Stocks To Guard Wealth - Sure Dividend
Abbott Labs Settles Illinois Medical History Privacy Lawsuit - Bloomberg Law News
Abbott (ABT) Launches Innovative Dual Glucose-Ketone Monitoring System - GuruFocus
Abbott secures CE mark for dual glucose-ketone sensing technology for diabetes patients - marketscreener.com
Abbott Laboratories stock (US0028241000): investors weigh diagnostics and growth drivers - AD HOC NEWS
Abbott secures CE mark for dual glucose-ketone sensor By Investing.com - Investing.com Canada
Abbott secures CE mark for dual glucose-ketone sensor - Investing.com
Abbott wins CE mark for dual glucose-ketone sensor - Drug Delivery Business
New Abbott sensor tracks glucose and ketones to flag DKA risk - Stock Titan
How Abbott's Diagnostics Unit Is Shaping Up Through the Rest of 2026 - Yahoo Finance
Goldman Sachs Adjusts Price Target on Abbott Laboratories to $113 From $121, Maintains Buy Rating - Moomoo
Abbott (ABT) Sees Cologuard and Cologuard Plus Confirmed in Upda - GuruFocus
ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening - PR Newswire
Abbott Laboratories stock (US0028241000): investors weigh diagnostics strength and medical-device he - AD HOC NEWS
Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026 - PR Newswire
Abbott Laboratories (ABT) Slid on Headwinds in Nutrition Business - Insider Monkey
Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Today's Market - The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Abbott Laboratories (ABT) Stock Analysis: Tapping Into A 35.73% Potential Upside - DirectorsTalk Interviews
Reassessing Abbott Laboratories (ABT) After A 32% One Year Share Price Decline - Yahoo Finance
Abbott Deepens Digital Health Push With New Cardiovascular Diagnostics And Wearables - simplywall.st
Abbott Laboratories stock is getting decimated, but the smart money senses opportunity - MSN
Abbott Laboratories Stock Is Getting Decimated, But the Smart Money Senses Opportunity - Barchart
Has the Abbott Laboratories Sell-Off Finally Created an Entry Point? - AOL.com
Abbott Laboratories (ABT) Slid Due To Its Nutrition Segment’s Sensitivity to Consumer Spending Momentum - Insider Monkey
Waiting on Integration Result, Market Stays Moderated on Abbott Laboratories (ABT) - Insider Monkey
Three Recession-Resistant Stocks Worth Investors’ Attention - NAI500
Abbott’s Lingo Wearable And Cardio R&D Reframe Long Term Growth Story - Yahoo Finance
Abbott Laboratories, Coca-Cola, and Walmart: Top Recession-Proof Stocks for 2026News and Statistics - IndexBox
Abbott Laboratories cuts outlook, says mild flu season hurt sales - MSN
Has the Abbott Laboratories sell-off finally created an entry point? - MSN
Long term debt to total equity ratio of Abbott Laboratories – BVL:ABTUS - TradingView
Abbott Laboratories Balance Sheet – BVL:ABTUS - TradingView
NEC Baby Formula Lawsuit & Settlement | May 2026 Update - Lawsuit Information Center
Buying pulsed field ablation systems: What hospitals should know - Modern Healthcare
3 Stocks to Buy if You Think the Economy Is Heading for a Recession - The Motley Fool
Abbott Laboratories stock (US0028241000): diabetes business and latest earnings in focus - AD HOC NEWS
Abbott Laboratories stock (US0028241000): investors eye upcoming Q4 2025 earnings call and biosimila - AD HOC NEWS
Better medical device stock right now: Abbott Laboratories vs. Dexcom - MSN
Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum - Yahoo Finance
Abbott Laboratories stock (US0028241000): steady medical devices player after latest quarterly updat - AD HOC NEWS
Worker says Abbott fired him over a chat his coworker started - hcamag.com
ECMC debuts new high-tech blood & urine lab to cut down on processing times by 20 percent - WKBW
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott Spinal Cord Stimulator Problems Resulted in Severe Paralysis: Lawsuit - AboutLawsuits.com
Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $109 - 富途牛牛
Abbott Laboratories Insiders Added US$4.23m Of Stock To Their Holdings - Yahoo Finance
0.83%
0.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):